NL97686C - - Google Patents

Info

Publication number
NL97686C
NL97686C NL97686DA NL97686C NL 97686 C NL97686 C NL 97686C NL 97686D A NL97686D A NL 97686DA NL 97686 C NL97686 C NL 97686C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL97686C publication Critical patent/NL97686C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL97686D 1956-04-30 NL97686C (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US811411XA 1956-04-30 1956-04-30

Publications (1)

Publication Number Publication Date
NL97686C true NL97686C (cg-RX-API-DMAC7.html)

Family

ID=22162337

Family Applications (1)

Application Number Title Priority Date Filing Date
NL97686D NL97686C (cg-RX-API-DMAC7.html) 1956-04-30

Country Status (2)

Country Link
GB (1) GB811411A (cg-RX-API-DMAC7.html)
NL (1) NL97686C (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313706A (en) * 1965-06-08 1967-04-11 Johnson & Johnson Diagnostic antigen for viral hepatitis
PT71739B (en) * 1979-09-04 1982-01-26 Merck & Co Inc Process for preparing a cell culture of hepatitis a virus
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus

Also Published As

Publication number Publication date
GB811411A (en) 1959-04-02

Similar Documents

Publication Publication Date Title
AT202855B (cg-RX-API-DMAC7.html)
AT216255B (cg-RX-API-DMAC7.html)
DE1071837B (cg-RX-API-DMAC7.html)
AT199361B (cg-RX-API-DMAC7.html)
AT202354B (cg-RX-API-DMAC7.html)
AT193789B (cg-RX-API-DMAC7.html)
AT202279B (cg-RX-API-DMAC7.html)
AT197702B (cg-RX-API-DMAC7.html)
AT195843B (cg-RX-API-DMAC7.html)
AT196732B (cg-RX-API-DMAC7.html)
AT201309B (cg-RX-API-DMAC7.html)
AT213780B (cg-RX-API-DMAC7.html)
AT194993B (cg-RX-API-DMAC7.html)
AT198843B (cg-RX-API-DMAC7.html)
AT198966B (cg-RX-API-DMAC7.html)
AT198677B (cg-RX-API-DMAC7.html)
AT201431B (cg-RX-API-DMAC7.html)
AT211020B (cg-RX-API-DMAC7.html)
AT197107B (cg-RX-API-DMAC7.html)
AT198039B (cg-RX-API-DMAC7.html)
AT198832B (cg-RX-API-DMAC7.html)
FR65655E (cg-RX-API-DMAC7.html)
AT196779B (cg-RX-API-DMAC7.html)
AT198038B (cg-RX-API-DMAC7.html)
AT196060B (cg-RX-API-DMAC7.html)